|
2026 Journal Article Pharmacokinetics of intravenous ciprofloxacin for Legionella pneumonia during prolonged intermittent kidney replacement therapy: a case report and literature reviewScott, Donna, Salman, Sam, Ingram, Paul, McWhinney, Brett, Ungerer, Jacobus, Morgan, David, Roberts, Jason A. and Rawlins, Matthew (2026). Pharmacokinetics of intravenous ciprofloxacin for Legionella pneumonia during prolonged intermittent kidney replacement therapy: a case report and literature review. Renal Replacement Therapy, 12 (1) 39. doi: 10.1186/s41100-026-00738-8 |
|
2026 Journal Article Antimicrobial prophylaxis regimens in joint replacement surgery: susceptibility and PK/PD target attainmentRivera, Alba, Luque, Sonia, Mur, Isabel, Puig-Verdié, Lluís, Gállego, Anna, Crusi, Xavier, Sorlí, Luisa, González, José Carlos, Horcajada, Juan Pablo, Navarro, Ferran, Roberts, Jason A. and Benito, Natividad (2026). Antimicrobial prophylaxis regimens in joint replacement surgery: susceptibility and PK/PD target attainment. International Journal of Antimicrobial Agents, 67 (11) 107947. doi: 10.1016/j.ijantimicag.2026.107947 |
|
2026 Journal Article Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patientsDorofaeff, Tavey, Hernández-Mitre, María Patricia, Liu, Xin, Guerra Valero, Yarmarly C., Coulthard, Mark G., Lipman, Jeffrey, Wallis, Steven C., Maresco-Pennisi, Diane L., Parker, Suzane L. and Roberts, Jason A. (2026). Population pharmacokinetics of piperacillin/tazobactam in critically ill pediatric patients. Antimicrobial Agents and Chemotherapy e00272-26. doi: 10.1128/aac.00272-26 |
|
2026 Journal Article Protein binding determination of cefepime, flucloxacillin, meropenem, piperacillin and tazobactam by ultrafiltration in critically ill patients: the choice of device mattersGregoire, Matthieu, Wallis, Steven C., Williams, Paul G., Won, Hayoung, Hernández-Mitre, María Patricia, Abdul-Aziz, Mohd H. and Roberts, Jason A. (2026). Protein binding determination of cefepime, flucloxacillin, meropenem, piperacillin and tazobactam by ultrafiltration in critically ill patients: the choice of device matters. Clinical Pharmacokinetics, 1-12. doi: 10.1007/s40262-026-01659-9 |
|
2026 Journal Article The effects of continuous venovenous hemofiltration on immunosuppressive drug concentrations in an ex-vivo model of the critically Ill Adult: (CITRIC) studyChumas, Lucy A., Wallis, Steven C., Sumi, Chandra, Abdul-Aziz, Mohd Hafiz, McWhinney, Brett C., Ungerer, Jacobus P. J., Coyer, Fiona, Ranganathan, Dwarakanathan, Roberts, Jason A. and Dhanani, Jayesh (2026). The effects of continuous venovenous hemofiltration on immunosuppressive drug concentrations in an ex-vivo model of the critically Ill Adult: (CITRIC) study. Artificial Organs aor.70211. doi: 10.1111/aor.70211 |
|
2026 Journal Article Focused Update to International Consensus Recommendations for the Use of Prolonged‐Infusion Beta‐Lactam Antibiotics Among Severely Ill Adult Patients: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases PharmacistsHong, Lisa T., FakhriRavari, Alireza, Ulldemolins, Marta, Roberts, Jason A., Bonomo, Robert A., Scheetz, Marc H. and the Prolonged‐Infusion Beta‐Lactam Consensus Panel (2026). Focused Update to International Consensus Recommendations for the Use of Prolonged‐Infusion Beta‐Lactam Antibiotics Among Severely Ill Adult Patients: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46 (9) e70188, e70188-e70188. doi: 10.1002/phar.70188 |
|
2026 Journal Article Physiological determinants of piperacillin and cefazolin clearance in septic and trauma patientsUlldemolins, Marta, Abdul-Aziz, Mohd Hafiz, Hernández-Mitre, María Patricia, Mohd Sazlly Lim, Sazlyna, Udy, Andrew A., Colmenero, Manuel, Kruger, Peter, Kirkpatrick, Carl M. J., Roberts, Michael S., Wallis, Steven C., Paterson, David L., Lipman, Jeffrey and Roberts, Jason A. (2026). Physiological determinants of piperacillin and cefazolin clearance in septic and trauma patients. Critical Care. doi: 10.1186/s13054-026-06239-8 |
|
2026 Journal Article Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainmentBoşnak, Cemre, Metan, Gökhan, Zarakolu, Pınar, Karakulak, Elifcan Aladağ, Pınar, Aslı, Göker, Hakan, Roberts, Jason A, Hernandez-Mitre, Maria Patricia and Akova, Murat (2026). Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment. Journal of Antimicrobial Chemotherapy, 81 (9) dkag284. doi: 10.1093/jac/dkag284 |
|
2026 Journal Article Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapyUlldemolins, Marta, Lipman, Jeffrey, Liu, Xin, Abdul-Aziz, Mohd-Hafiz, Baptista, João P., Bilgrami, Irma, Bitker, Laurent, Boidin, Clement, Brinkmann, Alexander, Cheng, Vesa, Choi, Gordon, Cole, C. Louise, De Waele, Jan J., Deans, Renae, Eastwood, Glenn M., Escobar, Leslie, Frey, Otto R., Garreau, Romain, Goutelle, Sylvain, Gresham, Rebecca, Hernandez-Mitre, Maria Patricia, Jamal, Janattul Ain, Joynt, Gavin M., Kanji, Salmaan, Kielstein, Jan T., Kluge, Stefan, König, Christina, Koulouras, Vasilios P., Lassig-Smith, Melissa ... and the ESCMID PK/PD of Anti-Infectives Study Group (EPASG) (2026). Vancomycin optimised dosing regimens for critically ill patients receiving renal replacement therapy. Critical Care. doi: 10.1186/s13054-026-06226-z |
|
2026 Journal Article Pharmacokinetic and pharmacokinetic/pharmacodynamic (PK/PD) considerations of ceftaroline and ceftobiprole for the treatment of Staphylococcus aureus infections: a systematic reviewGenovese, Camilla, Colaneri, Marta, Sguazzini, Enrico, Maddalena, Donatella, Abdul-Aziz, Mohd-Hafiz, Sime, Fekade B., Soriano, Alex, Gori, Andrea, Roberts, Jason A. and Ulldemolins, Marta (2026). Pharmacokinetic and pharmacokinetic/pharmacodynamic (PK/PD) considerations of ceftaroline and ceftobiprole for the treatment of Staphylococcus aureus infections: a systematic review. International Journal of Antimicrobial Agents 107959, 107959-107959. doi: 10.1016/j.ijantimicag.2026.107959 |
|
2026 Journal Article Population pharmacokinetics of total and free ceftriaxone in critically ill and non-critically ill hospitalised adult patientsSetiawan, Eko, Gonzalez, Alvaro, Wölky, Saskia A., Cotta, Menino Osbert, Liu, Xin, Sosilya, Hernycane, Maresco-Pennisi, Diane, Novy, Emmanuel, Ordonez, Jenny, Lukas, Dwi Lily, Wallis, Steven C., Xie, Jiao, Roberts, Jason A. and Abdul-Aziz, Mohd H. (2026). Population pharmacokinetics of total and free ceftriaxone in critically ill and non-critically ill hospitalised adult patients. International Journal of Antimicrobial Agents, 67 (8) 107817, 1-11. doi: 10.1016/j.ijantimicag.2026.107817 |
|
2026 Journal Article Consensus Guidance for Beta‐Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti‐Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases PharmacistsBarreto, Erin F., McCreary, Erin K., Pai Mangalore, Rekha, Tang Girdwood, Sonya, Arriola, Rebecca, Bens, Cynthia, Bonomo, Robert A., Edginton, Andrea N., Hong, Lisa T., Huttner, Angela, Koch, Birgit C. P., Maranchick, Nicole, Neely, Michael N., Peloquin, Charles R., Rao, Gauri G., Roberts, Jason A., Röhr, Anka C., Scheetz, Marc H., Schuetz, Audrey N., Yarnold, Paul R., Zuluaga, Andres and Rhodes, Nathaniel J. (2026). Consensus Guidance for Beta‐Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti‐Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46 (8) e70181, e70181-e70181. doi: 10.1002/phar.70181 |
|
2026 Journal Article Evaluation of short versus long course of tobramycin combined with piperacillin/tazobactam against antibiotic-resistant Pseudomonas aeruginosa in a hollow fibre infection modelWale, Yalew M., Roberts, Jason A., Won, Hayoung, Reghu, Sheethal, Marjanovic, Dusan, Assefa, Getnet M., Permana, Budi, Ford, Brian and Sime, Fekade B. (2026). Evaluation of short versus long course of tobramycin combined with piperacillin/tazobactam against antibiotic-resistant Pseudomonas aeruginosa in a hollow fibre infection model. Antibiotics, 15 (7) 685. doi: 10.3390/antibiotics15070685 |
|
2026 Journal Article Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteersLegg, Amy, Boast, Alison, Piera, Kim, Liu, Xin, Wallis, Steven C., McCarthy, James, Davis, Joshua S., Tong, Steven Y. C., Gwee, Amanda and Roberts, Jason A. (2026). Flucloxacillin plasma and urinary concentrations with and without probenecid and urinary biomarker profiles in healthy volunteers. British Journal of Clinical Pharmacology bcp.70663. doi: 10.1002/bcp.70663 |
|
2026 Journal Article Predictive performance of an antibiotic precision dosing software program in critically ill adults with infectionWilliams, Paul, Cotta, Menino Osbert, Wilks, Kathryn, Farkas, Andras, Spelman, Tim and Roberts, Jason A (2026). Predictive performance of an antibiotic precision dosing software program in critically ill adults with infection. Journal of Antimicrobial Chemotherapy, 81 (8) dkag234. doi: 10.1093/jac/dkag234 |
|
2026 Journal Article Optimizing intravenous amoxicillin for outpatient parenteral antimicrobial therapyWolie, Zenaw T, Roberts, Jason A, Wallis, Steven C, Assefa, Getnet M, Seaton, R Andrew, Gilchrist, Mark and Sime, Fekade B (2026). Optimizing intravenous amoxicillin for outpatient parenteral antimicrobial therapy. JAC-Antimicrobial Resistance, 8 (4) dlag165. doi: 10.1093/jacamr/dlag165 |
|
2026 Journal Article External validation of a model informed precision dosing software for cefotaxime for treating critical ill infants and childrenTu, Quyen, Raman, Sainath, Cotta, Menino Osbert, Schlapbach, Luregn, Dorofaeff, Tavey, Farkas, Andras and Roberts, Jason A (2026). External validation of a model informed precision dosing software for cefotaxime for treating critical ill infants and children. Journal of Antimicrobial Chemotherapy, 81 (8) dkag235. doi: 10.1093/jac/dkag235 |
|
2026 Journal Article The impact of an ex vivo paediatric renal replacement therapy circuit on antimicrobial concentrationsCree, Michele L., Abdul-Aziz, Mohd Hafiz, Wallis, Steven C., Won, Hayoung, Sumi, Chandra D., Marjanovic, Dusan, Ordonez, Jenny L., Schlapbach, Luregn J. and Roberts, Jason A. (2026). The impact of an ex vivo paediatric renal replacement therapy circuit on antimicrobial concentrations. Journal of Antimicrobial Chemotherapy, 81 (7) dkag189, 1-11. doi: 10.1093/jac/dkag189 |
|
2026 Journal Article Population pharmacokinetics of polymyxin B in critically ill patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infectionsZamri, Puteri Juanita, Wölky, Saskia A., Hernandez-Mitre, Maria P., Liu, Xin, Hasan, M. Shahnaz, Shariff, Izyani Md, Sulaiman, Helmi, Wallis, Steven C., Sumi, Chandra Datta, Parker, Suzanne L., Sime, Fekade Bruck, Roberts, Jason A. and Abdul-Aziz, Mohd Hafiz (2026). Population pharmacokinetics of polymyxin B in critically ill patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections. International Journal of Antimicrobial Agents, 67 (7) 107816, 1-11. doi: 10.1016/j.ijantimicag.2026.107816 |
|
2026 Journal Article A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shockSulaiman, Helmi, Wölky, Saskia A., Rozali, Muhammad Azrai, Adiraju, Santosh K. S., Hasan, M. Shahnaz, Hernandez-Mitre, Maria Patricia, Liu, Xin, Mat-Nor, Mohd-Basri, Mazlan, Mohd Zulfakar, Salmuna, Zeti Norfidiyati, Wallis, Steven C., Xie, Jiao, Roberts, Jason A. and Abdul-Aziz, Mohd H. (2026). A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock. The Journal of Antimicrobial Chemotherapy, 81 (7) dkag199. doi: 10.1093/jac/dkag199 |
